MDxHealth to Participate in the Rodman & Renshaw 16th

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MDxHealth to Participate in the Rodman & Renshaw 16th Annual Global Investment Conference

IRVINE, Calif. and HERSTAL, Belgium, Sept. 8, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that the company will participate in the Rodman & Renshaw 16th Annual Global Investment Conference in New York, NY.

Dr. Jan Groen, Chief Executive Officer of MDxHealth, will present a corporate overview at the Rodman & Renshaw 16 th Annual Global Investment Conference at the New York Palace Hotel at 4:10 p.m. ET on Tuesday, September 9, 2014

About ConfirmMDx® for Prostate Cancer

Over 975,000 American men are diagnosed with a negative prostate biopsy each year; however approximately 25-35% of those men receive false-negative results. Under the current standard of care, prostate biopsy procedures consisting of 10-12 needle biopsy cores only sample approximately 1% of a man's prostate. This approach leaves men at risk of occult cancer, leading to a high rate of repeat biopsies, often on cancer-free men. There is an unmet medical need for a clinically effective diagnostic test to address this dilemma.  ConfirmMDx for Prostate Cancer is able to detect an epigenetic field effect or 'halo' associated with the cancerization process at the DNA level. This "halo" around a cancer lesion can be present despite cells having a normal appearance under the microscope. Thus ConfirmMDx for Prostate Cancer aids urologists in identifying truly negative men who may forego an unnecessary repeat biopsy procedure.

About MDxHealth ®

MDxHealth is a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment. The company's tests are based on proprietary gene methylation (epigenetics) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth .

For more information:

Dr. Jan Groen, CEO             Mike Sinclair (media)    
MDxHealth Halsin Partners  
US: +1 949 812 6979 UK: +44 20 7318 2955   
BE: +32 4 364 20 70               Cell:+44 7968 022075    
info@mdxhealth.com msinclair@halsin.com  

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation.  This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of MDxHealth in any jurisdiction. No securities of MDxHealth may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. securities laws.

NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx and PredictMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

To access the PDF version, please click here http://hugin.info/137314/R/1854444/648528.pdf

HUG#1854444

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 86

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Ericsson Completes Major Buyback in November Burst

Updated Category News Views 81

Ericsson's Aggressive Share Repurchase Strategy Ericsson's share buyback spree might not be the first rodeo for seasoned investors out there, but their recent grab between November 9th and 13th surely made a few heads turn. The telecom giant snatched up a neat pile of 500,000 of its own Class B shares, maintaining the steady tick of their ambitious buyback program. It's...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 160

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
VIO Med Spa’s Black Friday Event: Aesthetic Savings

Updated Category News Views 61

Kicking Off the Holiday Season with a Glow Just when you think the holiday hustle can't get busier, VIO Med Spa is opening the gates of rejuvenation just in time to add yourself to that epic list. Starting November 16, VIO launches its Black Friday extravaganza—a deal-laden kick-off that means smooth skin and sharper looks are up for grabs. Member Benefits and Public...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 103

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 33

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 115

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 86

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 113

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Alliance for Women in Media Champions Change in 2026

Updated Category News Views 76

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading

Top 5 Most Recently Viewed Articles

SerpApi Reduces AI Token Use with Markdown Output

Updated Category News Views 80

A Big Leap for AI in Data Efficiency Well, here we are watching yet another tech company changing the game—or trying to, at least. SerpApi is shaking things up by announcing a new Markdown output feature, geared specifically toward AI developers. This is some impressive magic where structured search data gets spoon-fed to large language models (LLMs) in a format that's...

Continue Reading
Callinex Mines Reports Promising Exploration at Pine Bay

Updated Category News Views 195

Exploring New Horizons: Callinex Mines' Latest Discoveries Callinex Mines Inc. (TSXV: CNX) recently shared exciting updates from its exploration activities at the Pine Bay Camp, located in the Flin Flon Mining District. The drilling program has uncovered significant mineralization, particularly at the new Blueberry target area. Key Highlights from the Recent Drilling...

Continue Reading
Investor Concerns Grow Over Construction Partners, Inc. Shares

Updated Category News Views 136

Investor Concerns Grow Over Construction Partners, Inc. Shares Pomerantz LLP is currently examining claims on behalf of investors of Construction Partners, Inc. (NYSE: ROAD). This investigation aims to clarify whether the company’s management may have engaged in unlawful business practices or misrepresentation of its financial state. Understanding the Allegations Recent...

Continue Reading
Salesforce Earnings: Navigating Current Market Challenges

Updated Category News Views 75

Salesforce Stock Insights Amid Market Challenges Salesforce (NYSE: CRM) is facing notable resistance in its stock price, indicating potential difficulties in achieving new highs soon. While the recent Q2 results were encouraging, showcasing improved guidance, the market continues to grapple with various challenges. Issues such as slowing growth, macroeconomic pressures,...

Continue Reading
Investors Concerned About Synopsys, Inc. and Possible Losses

Updated Category News Views 147

Investigation into Synopsys, Inc. (SNPS) In recent times, Synopsys, Inc. has been under scrutiny for potential violations of federal securities laws. This investigation is particularly significant for the investors of Synopsys, Inc., commonly referred to as Synopsys. Understanding What Happened On September 9, 2025, Synopsys unveiled its financial results for the third...

Continue Reading